Sangamo Therapeutics Inc SGMO
NAS: SGMO | ISIN: US8006771062 17/01/2025
1,090 USD (-0,91%)
(-0,91%)
17/01/2025
Profiel Sangamo Therapeutics Inc
Website: www.sangamo.com
Hoofdzetel: Brisbane, California 
Verenigde Staten
CEO: Alexander Macrae
Werknemers: 520